Off-target Effect of CRISPR/Cas9 and Optimization

被引:0
作者
Guo Quan-Juan [1 ]
Han Qiu-Ju [1 ]
Zhang Jian [1 ]
机构
[1] Shandong Univ, Inst Immunopharmacol & Immunotherapy, Jinan 250012, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
gene editing; CRISPR/Cas9; off-target effects; single-guide RNA; CRISPR-CAS9; NUCLEASES; ESSENTIAL GENES; MOUSE MODEL; HUMAN-CELLS; GENOME; RNA; CAS9; DNA; IDENTIFICATION; SPECIFICITY;
D O I
10.16476/j.pibb.2018.0013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In recent years, CRISPR/Cas9 system has rapidly become the most revolutionary gene editing tool in the field of medicine. It is the third-generation artificial endonuclease after Zinc-finger nucleases (ZFNs) and transcription activator-like effectors nucleases (TALENs), and is known as "gene scissors". CRISPR/Cas9 system relies on a synthetic single guided RNA (sg RNA) to direct Cas9 nuclease to cleave the target DNA sequence, so that it can complete genomic site editing. Based on the simplicity of design, rapid implementation, low cost and high efficiency, CRISPR/Cas9 system has been extensively studied in the fields of gene functional identification, antiviral therapy, anti-tumor therapy and immunotherapy. Although CRISPR/Cas9 system displays several obvious advantages, the risk of off-target would increase the therapeutic risks, hinder research and clinical application, which should not be ignored. How to reduce the off-target effects and increase mutation efficiency simultaneously as we use CRISPR/Cas9 gene editing technology? This will be an urgent problem for scientists to explore CRISPR/Cas9 technology and expand its clinical application in the future. Here, we briefly introduce the composition, mechanism and application of CRISPR/Cas9 system, and give a comprehensive introduction of the off-target effect which is widely concerned in this field at present, and summarize the optimization strategies to provide references for researchers.
引用
收藏
页码:798 / 807
页数:10
相关论文
共 79 条
  • [1] An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance
    Bester, Assaf C.
    Lee, Jonathan D.
    Chavez, Alejandro
    Lee, Yu-Ru
    Nachmani, Daphna
    Vora, Suhani
    Victor, Joshua
    Sauvageau, Martin
    Monteleone, Emanuele
    Rinn, John L.
    Provero, Paolo
    Church, George M.
    Clohessy, John G.
    Pandolfi, Pier Paolo
    [J]. CELL, 2018, 173 (03) : 649 - +
  • [2] High-Efficiency Targeted Editing of Large Viral Genomes by RNA-Guided Nucleases
    Bi, Yanwei
    Sun, Le
    Gao, Dandan
    Ding, Chen
    Li, Zhihua
    Li, Yadong
    Cun, Wei
    Li, Qihan
    [J]. PLOS PATHOGENS, 2014, 10 (05)
  • [3] Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9
    Brunetti, Lorenzo
    Gundry, Michael C.
    Kitano, Ayumi
    Nakada, Daisuke
    Goodell, Margaret A.
    [J]. JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2018, (134):
  • [4] Assembly of CRISPR ribonucleoproteins with biotinylated oligonucleotides via an RNA aptamer for precise gene editing
    Carlson-Stevermer, Jared
    Abdeen, Amr A.
    Kohlenberg, Lucille
    Goedland, Madelyn
    Molugu, Kaivalya
    Lou, Meng
    Saha, Krishanu
    [J]. NATURE COMMUNICATIONS, 2017, 8
  • [5] Protospacer Adjacent Motif (PAM)-Distal Sequences Engage CRISPR Cas9 DNA Target Cleavage
    Cencic, Regina
    Miura, Hisashi
    Malina, Abba
    Robert, Francis
    Ethier, Sylvain
    Schmeing, T. Martin
    Dostie, Josee
    Pelletier, Jerry
    [J]. PLOS ONE, 2014, 9 (10):
  • [6] Enhanced proofreading governs CRISPR-Cas9 targeting accuracy
    Chen, Janice S.
    Dagdas, Yavuz S.
    Kleinstiver, Benjamin P.
    Welch, Moira M.
    Sousa, Alexander A.
    Harrington, Lucas B. .
    Sternberg, Samuel H.
    Joung, J. Keith
    Yildiz, Ahmet
    Doudna, Jennifer A.
    [J]. NATURE, 2017, 550 (7676) : 407 - +
  • [7] Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and Metastasis
    Chen, Sidi
    Sanjana, Neville E.
    Zheng, Kaijie
    Shalem, Ophir
    Lee, Kyungheon
    Shi, Xi
    Scott, David A.
    Song, Jun
    Pan, Jen Q.
    Weissleder, Ralph
    Lee, Hakho
    Zhang, Feng
    Sharp, Phillip A.
    [J]. CELL, 2015, 160 (06) : 1246 - 1260
  • [8] Applications of CRISPR/Cas System to Bacterial Metabolic Engineering
    Cho, Suhyung
    Shin, Jongoh
    Cho, Byung-Kwan
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (04)
  • [9] Classification and evolution of type II CRISPR-Cas systems
    Chylinski, Krzysztof
    Makarova, Kira S.
    Charpentier, Emmanuelle
    Koonin, Eugene V.
    [J]. NUCLEIC ACIDS RESEARCH, 2014, 42 (10) : 6091 - 6105
  • [10] Multiplex Genome Engineering Using CRISPR/Cas Systems
    Cong, Le
    Ran, F. Ann
    Cox, David
    Lin, Shuailiang
    Barretto, Robert
    Habib, Naomi
    Hsu, Patrick D.
    Wu, Xuebing
    Jiang, Wenyan
    Marraffini, Luciano A.
    Zhang, Feng
    [J]. SCIENCE, 2013, 339 (6121) : 819 - 823